Finally, the identification of a role for SNM1A in processing radiation-induced oxidative modified termini in DSBs raises the possibility that SNM1A inhibition might be used to reduce the doses of radiation treatment required to treat cancer. This evidence concerns the gene DCLRE1A and cancer.